Rivaroxaban - Bayer/Johnson & Johnson Pharmaceutical Research & Development
At a glance
- Drug Originator Bayer; Johnson & Johnson Pharmaceutical Research & Development
- Drug Licenced by Almirall S.A.
- Drug Class Amides; Anticoagulants; Antithrombotics; Cardiovascular therapies; Chlorinated hydrocarbons; Ketones; Morpholines; Oxazolidinones; Small molecules; Thiophenes
- Mechanism of Action Factor Xa inhibitors
- USA Patent Applicants JANSSEN PHARMS
- USA Patents 14
- NDAs 2
- International Patents 156
- Patent Applications 4,107
Table of Contents

Disclaimer